Hepatic neuromodulation using fluids or chemical agents
US9114123B2 · kind B2 · utility
38Cited by
89References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2014 |
| Grant date | Aug 25, 2015 |
| Priority date | — |
| Expiry date | Oct 31, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N7/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.